BioCatch selects DocuSign eSignature for Digital Signing

In 2021, BioCatch, a Israel based Professional Services organization with 170 employees and revenues of $17M selected DocuSign eSignature for Digital Signing while displacing Legacy, and integrating with the existing systems being used.

Customer	Vendor	Old Product	New Product	Category	Market	Users	VAR/SI	When	Live
BioCatch	DocuSign	Legacy	DocuSign eSignature	Digital Signing	Content Management	n/a	n/a	2021	2021

Discover the latest software purchases and digital transformation initiatives being undertaken by BioCatch and its business and technology executives by accessing the entire BioCatch and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by BioCatch employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.